Bayer Loses Yaz Patent in Federal Court of Appeals: Generic Yaz Versions Begin (Stealing) Marketshare
Bayer was recently dealt a setback in a Federal Court of Appeals in Washington. Their patent on Yaz, a contraceptive pill, was deemed to no longer be worthy of patent protection. Bayer’s patent on Yaz expires in June 2014. As a result of this ruling, Actavis Inc. and Novartis AG can sell generic versions of the birth control pill. Though the ruling now gives other pharmaceutical companies the ability to legally compete against Bayer in the drospirenone contraceptive pill market, generic and inexpensive versions of Yaz-like drugs are driving Continue Reading
Mirena IUD Lawyers at Carey Danis & Lowe Applaud Federal Mirena IUD Lawsuits Consolidation into MDL
A Judicial Panel on Multidistrict Litigation (JPML) recently ruled that all federal Mirena IUD lawsuits be consolidated into the U.S. District Court for the Southern District of New York. The JPML ordered that Judge Cathy Seibel hear the Mirena MDL proceedings, according to a HarrisMartin Publishing article. Plaintiffs who have cases in the Mirena IUD MDL No. 2434 filed their lawsuits against Bayer citing serious defects with the intrauterine contraceptive device. According to the plaintiffs, Mirena IUD side effects include the device becoming embedded in the uterus, and in Continue Reading
Discussions Underway in Forming Mirena MDL: Bayer Opposes Consolidating into Mirena MDL
Submit Your Claim A U.S. Judicial Panel on Multi-district Litigation (JPML) met on March 21 in San Diego, California to discuss the consolidation of Mirena IUD lawsuits into a multi-district litigation (MDL). Bayer, the manufacturer of the Mirena intrauterine device (IUD), has expressed a strong opposition against consolidation of lawsuits into an MDL. The German pharmaceutical company opposes the formation of a Mirena MDL, which the Judicial Panel is calling In re: Mirena IUD Products Liablity Litigation, MDL No. 2434, because Bayer believes that a Mirena MDL would stall Continue Reading
Yaz Gallbladder Lawsuit Update: Bayer Settles Gallbladder Injury Yaz and Yasmin Lawsuits for $24 Million
Submit Your Claim A settlement agreement has been reached between Bayer and plaintiffs who filed a Yaz and Yasmin lawsuit specifically citing gallbladder complications. The settlement agreement between the plaintiffs and Bayer, the German pharmaceutical company responsible for the development and marketing of Yaz and Yasmin, was reached on March 15. The plaintiffs’ Yaz gallbladder lawsuits against Bayer were filed in courts across the U.S., including a Yaz and Yasmin multi-district litigation (MDL) in the U.S. District Court for the Southern District of Illinois. The Yaz and Yasmin MDL Continue Reading
Bayer Allocates $1.5 Billion as a Yaz and Yasmin Legal Fund: Settlement Agreements Reached in Yaz and Yasmin Lawsuits
Submit Your Claim According to a Reuters report published on March 4, Bayer allocated $1.5 billion last year as a legal fund for Yaz and Yasmin lawsuits. In anticipation of future settlements of Yaz and Yasmin lawsuits, Bayer has set these funds aside, as it faces thousands more lawsuits. Bayer recently reached a settlement agreement of $1 billion in 4,800 lawsuits filed against them in the U.S. These nearly 5,000 lawsuits were filed against the German pharmaceutical company because, as the plaintiffs claim, ingestion of the contraceptives Yaz and Continue Reading
Lawyers at Carey Danis & Lowe Currently Evaluating Mirena Cases
Submit Your Claim Published February 20, 2013 by PR Web St. Louis, Missouri (PRWEB) February 20, 2013 To address the increasing number of adverse event reports associated with the use of the Mirena intrauterine device manufactured by Bayer(1), lawyers at Carey Danis & Lowe have launched a new website with useful information for individuals who may have used the Mirena IUD or know someone who has used the contraceptive device. The new webpage has information about health complications associated with use of Bayer’s Mirena IUD. In Carey Danis & Continue Reading
Carey Danis & Lowe Currently Evaluating Mirena Lawsuits: Lawyers Accepting Mirena Cases
Submit Your Claim Lawyers at Carey Danis & Lowe have been closely following recent news regarding Mirena lawsuits. Following growing adverse event reports filed with the U.S. Food and Drug Administration (FDA) as well as increasing numbers of Mirena lawsuits being filed across the country, Lawyers at Carey Danis & Lowe are currently offering free legal evaluations of Mirena cases. Manufactured by Bayer Healthcare Pharmaceuticals Inc. (Bayer), Mirena is a contraceptive device intended for long-term use of up to 5 years, and is recommended for use by women who Continue Reading
Federal Trade Commission Concludes Investigation into Bayer Pharmaceuticals and Yasmin Patent Litigation
Published October 12, 2012 by LawsuitInformation.org In recent news regarding Bayer Pharmaceuticals, the German pharmaceutical giant responsible for the manufacture of Yaz and Yasmin, the Federal Trade Commission made the decision to terminate its investigation into a patent settlement between Bayer and Teva Pharmaceuticals. In 2008, the two pharmaceutical companies reached an agreement in regards to Bayer’s claim that Barr Laboratories, which was ultimately purchased by Teva Pharmaceuticals, overstepped the boundaries of intellectual property protecting Bayer’s Yasmin patent. The 2008 settlement drew the attention of the FTC, and led Continue Reading
Bayer 2012 Profits Impacted by Yaz and Yasmin Lawsuits
Published August 23, 2012 on LawsuitInformation.org It has been reported that Bayer, the German pharmaceutical giant responsible for the development of Yaz and Yasmin, the health threatening birth control pills of ill repute, has created what is essentially a savings account in the amount of 500 million euros for the purpose of future Yaz and Yasmin lawsuits. In a study conducted by the U.S. Food and Drug Administration (FDA) of Yaz and Yasmin, the FDA uncovered the high risk of blood clot development and a number of other serious Continue Reading
Yaz/Yasmin DVT & Pulmonary Embolism Settlements Progressing
Published July 10, 2012 by LawsuintInformation As a Yaz Pulmonary Embolism, Deep Vein Thrombosis Attorney I have written extensively about the risks inherent in birth control pills containing Drospirenone. According to status report held on June 22, in the U.S. District Court for the Southern District of Illinois, Bayer has reached agreements with about 33 different law firms to resolve at least 1,444 Yaz Deep Vein Thrombosis, Stroke and Pulmonary Embolism claims. According to Bloomberg News, as of late April, Bayer faced 11,900 lawsuits over Yaz and its sister Continue Reading
